GlaxoSmithKline, Johnson & Johnson Aim To Improve Medicine Access, Affordability With New Strategies In Developing Countries

Devex: A new look for big pharma business in the developing world
“Pharmaceutical giants Johnson & Johnson and GlaxoSmithKline PLC are changing the way they do business in the developing world. Over the past week, both drug firms have announced significant revamps to their strategies in developing countries that aim to increase access to their treatments through relaxed patent protections and expanded partnerships with local health care providers…” (Mendoza, 4/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.